Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
  • Donate
Select Page
Video Premiere of 2022 Stem Cell & Regenerative Medicine Action Awards

Video Premiere of 2022 Stem Cell & Regenerative Medicine Action Awards

by admin | Jun 9, 2022 | News & Opinions, Video, Video Chats

On June 9 at 7:00 PM EDT, Regenerative Medicine Foundation (RMF) broadcast the Stem Cell and Regenerative Medicine Action Awards as part of the combined virtual 17th annual World Stem Cell Summit (WSCS) and Wake Forest Institute for Regenerative Medicine and RMF’s...
Saudi Arabia plans to spend  billion a year discovering treatments to slow aging

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

by Admin | Jun 9, 2022 | News & Opinions

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin. By Antonio Regalado technologyreview.com – link to article Anyone who has more money than...
Cell Bridge Strategies Sponsors “Regenerative Medicine and Cell Therapy – The India Landscape” Session at Virtual World Stem Cell Summit, June 6-11

Cell Bridge Strategies Sponsors “Regenerative Medicine and Cell Therapy – The India Landscape” Session at Virtual World Stem Cell Summit, June 6-11

by admin | Jun 2, 2022 | News & Opinions

Boerne, TX. June 1, 2022 — Cell Bridge Strategies, an industry thought leader and consulting firm for Regenerative Medicine and the Advanced Therapies announced its sponsorship and design of an executive-level panel session to address the significant impact India is...
The power of the patient advocate: how a quick visit led to an M grant to fund a clinical trial

The power of the patient advocate: how a quick visit led to an $11M grant to fund a clinical trial

by Admin | May 31, 2022 | News & Opinions

By Kevin McCormack – Link to article – CIRM At the California Institute for Regenerative Medicine (CIRM) we are fortunate in having enough money to fund the most promising research to be tested in a clinical trial. Those are expensive projects, often costing tens of...
Regenerative Medicine Foundation (RMF) Proudly Presents The 2022 “Stem Cell and Regenerative Medicine Action Award” Honorees

Regenerative Medicine Foundation (RMF) Proudly Presents The 2022 “Stem Cell and Regenerative Medicine Action Award” Honorees

by Admin | May 25, 2022 | News & Opinions

2022 Honorees include  Arnold I. Caplan, PhD;  Dr. Mahendra Rao;  Frances Verter, PhD & The Parent’s Guide to Cord Blood Foundation and the Maryland Stem Cell Research Fund On June 9 at 7:00 PM EDT, Regenerative Medicine Foundation (RMF) will broadcast the Stem...
Rejuvenating human beings: the rise of cellular reprogramming

Rejuvenating human beings: the rise of cellular reprogramming

by Admin | May 25, 2022 | News & Opinions

Cellular reprogramming is on the up as a growing number of companies race to develop therapies for rejuvenating human beings. Author: Eleanor Garth – Longevity.Technology – Link to article Recent advances in cellular reprogramming have revolutionised the...
Page 158 of 217« First«157158159»Last »

Recent Posts

  • Leveraging the Full Potential of Regenerative Medicine Requires a Proactive Approach
  • Implantable islet cells could control diabetes without insulin injections
  • RNA-guided CRISPR system activates gene expression
  • UCLA researchers receive $13.9 million CIRM grant to identify drug targets for autism and schizophrenia using human stem cell models
  • After allogeneic transplant, VIC-1911 regimen shows low severe GVHD and no relapse
Tweets about @WSCSummit